Topics

Glioblastoma | Treatment | Clinical trials | Viruses

Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Viruses

*Rossmeisl JH, King JN, Robertson JL, Weger-Lucarelli J, Elankumaran S.
Phase I/II Trial of Urokinase Plasminogen Activator-Targeted Oncolytic Newcastle Disease Virus for Canine Intracranial Tumors.
Cancers (Basel). 2024 Jan 29;16(3):564. doi: 10.3390/cancers16030564. PMID: 38339315. Interventional animal study. ˍ

Gunasegaran B, Ashley CL, Marsh-Wakefield F, Guillemin GJ, Heng B.
Viruses in glioblastoma: an update on evidence and clinical trials.
BJC Rep. 2024 Apr 19;2(1):33. doi: 10.1038/s44276-024-00051-z. PMID: 39516641. Review. ˍ

Daftari M, Ramsoomair CK, Aaronson D, Seetharam D, Andreae EA, Wright L, Han S, Chandar J, Lu V, Govindarajan V, Ivan ME, Komotar RJ, de la Fuente M, Shah AH.
Synergistic Treatment with Antiretrovirals and Laser Interstitial Thermal ThErapy (STARLITE) for unresectable glioblastoma: A phase 1 study protocol.
PLoS One. 2025 Aug 28;20(8):e0328204. doi: 10.1371/journal.pone.0328204. PMID: 40875628. Interventional study protocol. ˍ

Zeng W, Wang P, Fang S, Ge S, Jia W, Peng S, Wang M, Qin X, Zhang W, Gao J, Su X, Yuan G, Wu J, Liu Y, Wang Y, Lu H, Mu R, Wu F, Chang Q, Jin G, Meng F, Zhang J, Liu F.
ON-01, an engineered recombinant oncolytic herpes simplex virus type-1, in recurrent glioma: a single-arm, phase 1/2 study.
Neuro Oncol. 2026 Jan 12:noag005. doi: 10.1093/neuonc/noag005. PMID: 41527280. Interventional study. ˍ